Cervix BT - 2016

TMH EMBRACE Data Prospective MR Based Brachytherapy Dec 2009 – March 2014 N = 100 patients

Total no of patients Median Age (range)

47/100 patients

51 + 8 (28-65) years

Histology

40 05 02 47 18 25 04

Squamous Carcinoma Adenocarcinoma AdenoSquamous

FIGO Stage (n)

IIB

IIIB IVA

Intracavitary Brachytherapy (HDR)

4 fractions of 7 Gy to HRCTV

Median follow-Up (Range)

16 + 8.3 (7-36) months